Important clinical data for cefadroxil from @bradspellberg.bsky.social et al. Impressive 0% grade 3/4 adverse events (fits my clinical experience) and a great option for oral transition

Show Post

🔥Wow. Our article is published with the legend @bradspellberg.bsky.social 🎉🔥 A journey that started with a simple question: What’s in a name? Today, I’m incredibly grateful to see our article published in @cmicomms.bsky.social EnJoy! #idsky www.cmi-comms.org/article/S295...

Show Post

Is oral switch to amoxicillin an appropriate therapy for Listeria bloodstream infection? #IDSky @bradspellberg.bsky.social @idiots-pod.bsky.social @drrossanarosa.bsky.social

Show Post

Updated “Shorter Is Better” tables — now including the new pediatric neutropenic fever trial. That makes 4 neutropenic fever trials supporting the HOW LONG criteria. Are there still oncologists in denial? 👀 #idsky @bradspellberg.bsky.social

Show Post

I don’t think there is any good data for GNRs and risk of IE as far as number of bottles positive goes. But I did like this paper from @bradspellberg.bsky.social et al showing number of positive bottles helps risk stratify for gram positives! pmc.ncbi.nlm.nih.gov/articles/PMC...

Show Post